Invention Grant
- Patent Title: Pyridazinyl derivatives as smo inhibitors
- Patent Title (中): 哒嗪衍生物作为抑制剂
-
Application No.: US13553870Application Date: 2012-07-20
-
Publication No.: US08481542B2Publication Date: 2013-07-09
- Inventor: Feng He , Stefan Peukert , Karen Miller-Moslin , Naeem Yusuff , Zhuoliang Chen , Bharat Lagu
- Applicant: Feng He , Stefan Peukert , Karen Miller-Moslin , Naeem Yusuff , Zhuoliang Chen , Bharat Lagu
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Scott W. Reid
- Main IPC: C07D403/14
- IPC: C07D403/14 ; C07D401/14 ; A61K31/501 ; A61P35/00
Abstract:
The present invention relates to compounds of formula I: in which R11 and R12 are defined in the Summary of the Invention; capable of inhibiting the Hedgehog and Smo signaling pathway. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the diagnosis and treatment of pathologies relating to the Hedgehog and Smo signaling pathway, for example, tumor formation, cancer, neoplasia and non-malignant hyperproliferative disorders.
Public/Granted literature
- US20120289507A1 ORGANIC COMPOUNDS AS SMO INHIBITORS Public/Granted day:2012-11-15
Information query
